摘要
阐明了平喘药物的临床药理及作用机制,从给药方式、注意事项、不良反应等方面详尽阐述,以促进平喘药物的合理应用。
出处
《中国现代药物应用》
2010年第19期233-235,共3页
Chinese Journal of Modern Drug Application
参考文献9
-
1Sheley RS,Thomas MO,Edwin ES.Meta-analysis:respiratory tolerance to regularβ2-agonist use in patients withasthmal.Ann Intern Med,2004,140:802.
-
2徐治波,冯玉麟.β_2受体激动剂的合理应用评价[J].中国医院用药评价与分析,2007,7(5):325-328. 被引量:6
-
3中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3563
-
4Politiek M J,Boorsman M,Aalbers R.Comparison of formoterol and salbutamol and salmeterol in methacholine-induced severe broncho-constriction.EurRe~ir J,1999,13(5):988.
-
5顾明,赵杰东,徐芳雄.选择性β2受体激动剂的发展与临床应用[J].西南军医,2008,10(5):115-117. 被引量:5
-
6银春,冯玉麟.茶碱的作用机制及在慢性阻塞性肺疾病中的应用[J].临床肺科杂志,2008,13(7):885-887. 被引量:23
-
7Ieo K,Lim S,Caramori C,et al.A molecular mechamiam of action of theophylline induction of histane deaceeylase aceivity to lecrease,infllam matory gene expression.Proc Natl Acad Sci USA,2002,99:8926.
-
8Barnes PJ.ThcophyUine:new perspectives for all old drug.Am J Re-spri Crit Care Med,2003,167(6):813-818.
-
9殷凯生.支气管哮喘治疗中的几个新概念和新方法[J].中华结核和呼吸杂志,2005,28(11):746-748. 被引量:24
二级参考文献24
-
1Fazio R, Lafortuma C. Effect of inhaled salbutamol in mucociliary clearance in patients with chronic bronchitis [ J ]. Chest, 1981, 80:827.
-
2Shelley RS, Thomas MO, Edwin ES. Meta - analysis: respiratory tolerance to regular β2 - agonist use in patients with asthma[J]. Ann Intern Med, 2004, 140: 802.
-
3Zaugg M, Schaub MC, Pasch T, et al. Modulation of β - adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action[J]. Br J A naesth, 2002, 88: 101.
-
4Guyatt GH, Townsend M, Pugsley SO, et al. Bronchodilatiors in chronic airflow limitation. Effects on airway function, exercise capacity and quality of life[J]. Am Rev Respir Dis, 1987, 135 : 1 069.
-
5Bellman M J, Botnick, Shin JW. Inhaled bronchodilators redece dynamic hyperinflation during exercise in patients with patients with chronic destructive pulmonary disease[J]. Am J R espir Crit Care Med , 1996,153:967.
-
6Barnes PJ. Scientific rationale for inhaled combination therapy with long- acting β2 - agonists and corticosteroids [ J ]. Eur Respir J, 2002, 19:182.
-
7Karpel JP, Pesin J, Greenberg D, et al. A comparison of the effects of inratropium bromide and metaproterenol sulfate in acute exacerbations of COPD[ J]. Chest, 1990, 98:835.
-
8Gross NJ, Bankwala Z. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta- adrenergic agent[J]. Am Rev Respir Dis, 1987,136: 1 091.
-
9Barnes PJ. Theophylline : new perspectives for an old drug. Am J Respir Crit Care Med, 2003,167(6) : 813 -818.
-
10Rabe KF, Magnussen H, Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J, 1995,8:637 - 642.
共引文献3608
-
1黄海臣.布地奈德福莫特罗吸入剂治疗支气管哮喘缓解期的疗效[J].中国合理用药探索,2019,0(12):128-130. 被引量:3
-
2赵舒梅,龚晓燕,胡骏,狄宽,单进军,王和生,张聪,刘兰英.基于血清代谢组学与网络药理学研究咳喘停穴位贴敷治疗哮喘的效应物质与作用机制[J].中国中药杂志,2022,47(24):6780-6793. 被引量:14
-
3周妍,张旻.我国轻度支气管哮喘诊治现状及对策[J].诊断学理论与实践,2023,22(6):520-526. 被引量:4
-
4赵鑫蕊,吕柄男,梁国彩,刘亚群.平喘汤联合泼尼松对支气管哮喘患者的治疗效果及血清INF-γ、IL-1β、CCL-3水平的影响分析[J].四川中医,2023,41(10):116-119. 被引量:7
-
5张余赛.孟鲁司特钠联合沙丁胺醇治疗重度支气管哮喘的临床疗效及安全性分析[J].医药论坛杂志,2021,42(21):83-87. 被引量:3
-
6潘霞,乔世举.西药联合喘可治穴位注射治疗支气管哮喘的疗效观察[J].中国民族民间医药,2019,28(13):123-125. 被引量:3
-
7张爱丽.中西医结合治疗支气管哮喘慢性持续期临床观察[J].中国民族民间医药,2019,28(12):84-85. 被引量:7
-
8赵祥,陆明,刘佳鑫,韩夏,袁俐.甲基黄嘌呤生物碱作用概述[J].医学信息,2017,30(1):18-21.
-
9薄华利.中药平喘合剂联合地塞米松雾化吸入治疗支气管哮喘疗效观察[J].医学信息(医学与计算机应用),2014,0(35):340-340.
-
10曹毅.老年重症哮喘应用循证护理对改善患者生存质量影响分析[J].医学信息(医学与计算机应用),2014,0(35):117-117. 被引量:1
同被引文献23
-
1Global initiative for asthma. Global Strategy For Asthma Management And Prevention[ S]. America, 2011 : 1-124.
-
2Spears M, Donnelly I, Jolly L, et al. Effect of low-dose theophylline plus beclomethasone on lung function in smokers with asthma: a pilotstudy[J]. Eur Respir J, 2009, 33(5) : 1010-1017.
-
3Hatzeimann A, Morcillo EJ, Lungarella G, et al. The preclinical pharmacology of roflumilast-a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease [J]. Pulm Pharmaeol Ther, 2010, 23(4) : 235-256.
-
4Barnes N, Pavord I, Chuchalin A, et al. A randomized, doubleblind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma [ J ]. Clin Exp Allergy, 2012, 42 ( 1 ) : 38-48.
-
5Pettipher R, Hunter MG, Perkins CM, et al. Heightened response of eosinophilie asthmatic patients to the CRTH2 antagonist 0C000459. Allergy[J]. 2014, 69(9) : 1223-1232.
-
6Singh D, Cadden P, Hunter M, et al. Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 [J]. EurRespirJ, 2013, 41(1): 46-52.
-
7Slager RE, Otulana BA, Hawkins GA, et al. IL4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti- IL4 receptor alpha antagonist [ J]. J Allergy Clin Immunol, 2012, 130(2) : 516-522.
-
8Beeh KM, Kanniess F, Wagner F, et al. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma [ J ]. J Allergy Clin Immunol, 2013, 13! (3) : 866-874.
-
9殷凯生.应正确合理地应用平喘药物[J].国际呼吸杂志,2009,29(1):1-4. 被引量:3
-
10方晓聪,白春学.新一代超长效支气管扩张剂——茚达特罗[J].国际呼吸杂志,2010,30(9):572-575. 被引量:3
二级引证文献6
-
1彭瑾,刘同华.支气管哮喘药物的临床应用对比[J].中华肺部疾病杂志(电子版),2015,8(6):104-106. 被引量:6
-
2李秀凤.孟鲁司特治疗儿童支气管哮喘的效果[J].中国当代医药,2016,23(19):128-130. 被引量:1
-
3姜毅,宋显相,朱凯,管敏昌,杭金国.血液白细胞介素-8表达对哮喘儿童个体化治疗的参考价值[J].中国卫生检验杂志,2016,26(23):3392-3394. 被引量:4
-
4郑雪梅.药学监护在支气管哮喘住院患者临床治疗中的应用[J].甘肃科技,2017,33(24):133-134.
-
5徐林松.多索茶碱治疗支气管哮喘的肺功能和临床疗效分析[J].中国现代药物应用,2016,10(24):70-72. 被引量:8
-
6孙晓男,赵艳楠.理肺化瘀汤加减联合硫酸特布他林雾化液治疗支气管哮喘的临床观察[J].河北中医,2020,42(11):1660-1664. 被引量:2
-
1吴镝.膏方的正确服用与注意[J].中国医药指南,2012,10(10):289-290. 被引量:6
-
2王停,周刚,赵保胜,张林.中药新药研发策略分析[J].中国新药杂志,2017,26(8):865-871. 被引量:18
-
3谢沐风.仿制药研发中有关物质研究思路之我见[J].中国医药工业杂志,2013,44(11):1174-1183. 被引量:10
-
4王小平.细胞凋亡与子宫肌瘤发生和发展的相关性研究[J].中国生育健康杂志,2012,23(3):240-240. 被引量:3
-
52000年全球聚焦羊胎素[J].饮食科学,2001(10):31-31.
-
6BruggeJS,赵立超.用于药物设计的新的细胞内靶点[J].国外医学(药学分册),1994,21(2):71-73. 被引量:3
-
7洪小栩,陈慧诚(综述),李琦涵(审校).预防性人乳头瘤病毒疫苗研究进展[J].国际生物制品学杂志,2010,33(6):297-302.
-
8王一镗急诊医学一书的简介[J].岭南急诊医学杂志,2008,13(5):343-343.
-
9王一镗急诊医学一书的简介[J].岭南急诊医学杂志,2008,13(2):142-142.
-
10陈京,徐攀,姚振生.浙西南畲族常用蕨类植物药[J].江西中医学院学报,2012,24(4):30-33.